What chick and mouse models have taught us about the role of the endocardium in congenital heart disease

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 6, 2011, Pages 511-525

  Delaughter, Daniel M ^a   Saint Jean, Leshana ^a   Baldwin, H Scott ^a,b   Barnett, Joey V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Congenital heart disease; Endocardium; Epithelial mesenchymal transformation; Trabeculation; Valves

Indexed keywords

ANGIOPOIETIN RECEPTOR; BONE MORPHOGENETIC PROTEIN 2; BRG1 PROTEIN; CD31 ANTIGEN; COLLAGEN TYPE 1; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HYALURONAN SYNTHASE 2; HYALURONIC ACID; MYOCYTE ENHANCER FACTOR 2; NEU DIFFERENTIATION FACTOR; NOTCH1 RECEPTOR; SMAD6 PROTEIN; TIE 1 RECEPTOR; TIE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR TAL1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VERSICAN; WNT PROTEIN;

APOPTOSIS; ARTERIAL TRUNK; ATRIOVENTRICULAR CANAL; BICUSPID AORTIC VALVE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL INVASION; CELL POPULATION; CELL STRUCTURE; CELL TRANSFORMATION; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; ENDOCARDIAL CUSHION; ENDOCARDIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HEART VALVE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; NEURAL CREST CELL; NONHUMAN; PHENOTYPE; PHOTOTRANSDUCTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CHICK EMBRYO; DISEASE MODELS, ANIMAL; ENDOCARDIUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DEFECTS, CONGENITAL; MICE; SIGNAL TRANSDUCTION;

VERTEBRATA;

EID: 79958171660     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20809     Document Type: Review

References (173)

1. Abdelwahid E, Rice D, Pelliniemi LJ, Jokinen E. 2001. Overlapping and differential localization of Bmp-2, Bmp-4, Msx-2 and apoptosis in the endocardial cushion and adjacent tissues of the developing mouse heart. Cell Tissue Res 305: 67-78.
2. Aikawa E, Whittaker P, Farber M, et al. 2006. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113: 1344-1352.
3. Akiyama H, Chaboissier MC, Behringer RR, et al. 2004. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci U S A 101: 6502-6507.
4. Angel PM, Nusinow D, Brown CB, et al. 2011. Networked-based characterization of extracellular matrix proteins from adult mouse pulmonary and aortic valves. J Proteome Res 10: 812-823.
5. Araki T, Mohi MG, Ismat FA, et al. 2004. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med 10: 849-857.
6. Baldwin HS. 1996. Early embryonic vascular development. Cardiovasc Res 31 Spec No: E34-45.
7. Baldwin HS, Jensen KL, Solursh M. 1991. Myogenic cytodifferentiation of the precardiac mesoderm in the rat. Differentiation 47: 163-172.
8. Baldwin HS, Shen HM, Yan HC, et al. 1994. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120: 2539-2553.
9. Baldwin HS, Solursh M. 1989. Degradation of hyaluronic acid does not prevent looping of the mammalian heart in situ. Dev Biol 136: 555-559.
10. Barnett JV, Desgrosellier JS. 2003. Early events in valvulogenesis: a signaling perspective. Birth Defects Res Part C Embryo Today 69: 58-72.
11. Bartram U, Molin DG, Wisse LJ, et al. 2001. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 103: 2745-2752.
12. Beppu H, Malhotra R, Beppu Y, et al. 2009. BMP type II receptor regulates positioning of outflow tract and remodeling of atrioventricular cushion during cardiogenesis. Dev Biol 331: 167-175.
13. Bernanke DH, Markwald RR. 1982. Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. Dev Biol 91: 235-245.
14. Brown CB, Boyer AS, Runyan RB, Barnett JV. 1996. Antibodies to the type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol 174: 248-257.
15. Brown CB, Boyer AS, Runyan RB, Barnett JV. 1999. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283: 2080-2082.
16. Brutsaert DL, De Keulenaer GW, Fransen P, et al. 1996. The cardiac endothelium: functional morphology, development, and physiology. Prog Cardiovasc Dis 39: 239-262.
17. Bultman S, Gebuhr T, Yee D, et al. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6: 1287-1295.
18. Butcher JT, Markwald RR. 2007. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci 362: 1489-1503.
19. Butcher JT, Norris RA, Hoffman S, et al. 2007. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 302: 256-266.
20. Camenisch TD, Molin DG, Person A, et al. 2002a. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248: 170-181.
21. Camenisch TD, Schroeder JA, Bradley J, et al. 2002b. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 8: 850-855.
22. Camenisch TD, Spicer AP, Brehm-Gibson T, et al. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360.
23. Chan-Thomas PS, Thompson RP, Robert B, et al. 1993. Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick. Dev Dyn 197: 203-216.
24. Cheifetz S, Bellón T, Calés C, et al. 1992. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
25. Chen B, Bronson RT, Klaman LD, et al. 2000. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24: 296-299.
26. Chen YH, Ishii M, Sucov HM, Maxson REJr. 2008. Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol 8: 75.
27. Chen ZF, Behringer RR. 1995. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9: 686-699.
28. Cohen-Gould L, Mikawa T. 1996. The fate diversity of mesodermal cells within the heart field during chicken early embryogenesis. Dev Biol 177: 265-273.
29. Combs MD, Yutzey KE. 2009. Heart valve development: regulatory networks in development and disease. Circ Res 105: 408-421.
30. Compton LA, Potash DA, Brown CB, Barnett JV. 2007. Coronary vessel development is dependent on the type III transforming growth factor beta receptor. Circ Res 101: 784-791.
31. de la Pompa JL, Timmerman LA, Takimoto H, et al. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186.
32. Del Monte G, Grego-Bessa J, Gonzalez-Rajal A, et al. 2007. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn 236: 2594-2614.
33. DeRuiter MC, Poelmann RE, VanderPlas-de Vries I, et al. 1992. The development of the myocardium and endocardium in mouse embryos. Fusion of two heart tubes? Anat Embryol (Berl) 185: 461-473.
34. Desgrosellier JS, Mundell NA, McDonnell MA, et al. 2005. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 280: 201-210.
35. Dewulf N, Verschueren K, Lonnoy O, et al. 1995. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136: 2652-2663.
36. Dickson MC, Slager HG, Duffie E, et al. 1993. RNA and protein localisations of TGF beta 2 in the early mouse embryo suggest an involvement in cardiac development. Development 117: 625-639.
37. Dodou E, Verzi MP, Anderson JP, et al. 2004. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131: 3931-3942.
38. Drake CJ, Brandt SJ, Trusk TC, Little CD. 1997. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev Biol 192: 17-30.
39. Dumont DJ, Gradwohl G, Fong GH, et al. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897-1909.
40. Enciso JM, Gratzinger D, Camenisch TD, et al. 2003. Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160: 605-615.
41. Erickson SL, O'Shea KS, Ghaboosi N, et al. 1997. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124: 4999-5011.
42. Ferdous A, Caprioli A, Iacovino M, et al. 2009. Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo. Proc Natl Acad Sci U S A 106: 814-819.
43. Flagg AE, Earley JU, Svensson EC, et al. 2007. FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart. Dev Biol 304: 308-316.
44. Frieden LA, Townsend TA, Vaught DB, et al. 2010. Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1. Dev Dyn 239: 3226-3234.
45. Galvin KM, Donovan MJ, Lynch CA, et al. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24: 171-174.
46. Garg V, Kathiriya IS, Barnes R, et al. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
47. Garg V, Muth AN, Ransom JF, et al. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270-274.
48. Gassmann M, Casagranda F, Orioli D, et al. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378: 390-394.
49. Gelb BD, Tartaglia M. 2006. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet 15 Spec No 2: R220-226.
50. Gitler AD, Zhu Y, Ismat FA, et al. 2003. Nf1 has an essential role in endothelial cells. Nat Genet 33: 75-79.
51. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, et al. 1998. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 82: 1043-1052.
52. Goumans MJ, Valdimarsdottir G, Itoh S, et al. 2003. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828.
53. Goumans MJ, Valdimarsdottir G, Itoh S, et al. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 21: 1743-1753.
54. Hamburger V, Hamilton HL. 1992. A series of normal stages in the development of the chick embryo. 1951. Dev Dyn 195: 231-272.
55. Hinton RBJr, Lincoln J, Deutsch GH, et al. 2006. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98: 1431-1438.
56. Hurle JM, Colveé E. 1983. Changes in the endothelial morphology of the developing semilunar heart valves. A TEM and SEM study in the chick. Anat Embryol (Berl) 167: 67-83.
57. Hurle JM, Colveé E, Blanco AM. 1980. Development of mouse semilunar valves. Anat Embryol (Berl) 160: 83-91.
58. Hurlstone AF, Haramis AP, Wienholds E, et al. 2003. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425: 633-637.
59. Inai K, Norris RA, Hoffman S, et al. 2008. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol 315: 383-396.
60. Ishii Y, Langberg J, Rosborough K, Mikawa T. 2009. Endothelial cell lineages of the heart. Cell Tissue Res 335: 67-73.
61. Iwamoto R, Yamazaki S, Asakura M, et al. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A 100: 3221-3226.
62. Jackson LF, Qiu TH, Sunnarborg SW, et al. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. Embo J 22: 2704-2716.
63. Jain R, Engleka KA, Rentschler SL, et al. 2011. Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. J Clin Invest 121: 422-430.
64. Jiao K, Langworthy M, Batts L, et al. 2006. Tgfbeta signaling is required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development. Development 133: 4585-4593.
65. Kattman SJ, Huber TL, Keller GM. 2006. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11: 723-732.
66. Kern CB, Twal WO, Mjaatvedt CH, et al. 2006. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 235: 2238-2247.
67. Kirby ML. 1993. Cellular and molecular contributions of the cardiac neural crest to cardiovascular development. Trends Cardiovasc Med 3: 18-23.
68. Kirk EP, Sunde M, Costa MW, et al. 2007. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 81: 280-291.
69. Kirkbride KC, Townsend TA, Bruinsma MW, et al. 2008. Bone morphogenetic proteins signal through the transforming growth factor-{beta} type III receptor. J Biol Chem 283: 7628-7637.
70. Kisanuki YY, Hammer RE, Miyazaki J, et al. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230-242.
71. Kouskoff V, Lacaud G, Schwantz S, et al. 2005. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 102: 13170-13175.
72. Kramer R, Bucay N, Kane DJ, et al. 1996. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci U S A 93: 4833-4838.
73. Kretzschmar M, Massagué J. 1998. SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 8: 103-111.
74. Krug EL, Mjaatvedt CH, Markwald RR. 1987. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Dev Biol 120: 348-355.
75. Kruzynska-Frejtag A, Machnicki M, Rogers R, et al. 2001. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103: 183-188.
76. Kuo CT, Morrisey EE, Anandappa R, et al. 1997. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11: 1048-1060.
77. Lai YT, Beason KB, Brames GP, et al. 2000. Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation. Dev Biol 222: 1-11.
78. Lakkis MM, Epstein JA. 1998. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125: 4359-4367.
79. Lebrin F, Goumans MJ, Jonker L, et al. 2004. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. Embo J 23: 4018-4028.
80. Lee NY, Ray B, How T, Blobe GC. 2008. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 283: 32527-32533.
81. Lee RK, Stainier DY, Weinstein BM, Fishman MC. 1994. Cardiovascular development in the zebrafish. II. Endocardial progenitors are sequestered within the heart field Development 120: 3361-3366.
82. Liberatore CM, Yutzey KE. 2004. Calcineurin signaling in avian cardiovascular development. Dev Dyn 229: 300-311.
83. Liebner S, Cattelino A, Gallini R, et al. 2004. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166: 359-367.
84. Lin AE, Birch PH, Korf BR, et al. 2000. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 95: 108-117.
85. Linask KK. 1992. N-cadherin localization in early heart development and polar expression of Na+, K(+)-ATPase, and integrin during pericardial coelom formation and epithelialization of the differentiating myocardium. Dev Biol 151: 213-224.
86. Linask KK, Lash JW. 1993. Early heart development: dynamics of endocardial cell sorting suggests a common origin with cardiomyocytes. Dev Dyn 196: 62-69.
87. Lincoln J, Kist R, Scherer G, Yutzey KE. 2007. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol 305: 120-132.
88. Loomes KM, Taichman DB, Glover CL, et al. 2002. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 112: 181-189.
89. Lopez-Casillas F, Cheifetz S, Doody J, et al. 1991. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67: 785-795.
90. Luetteke NC, Phillips HK, Qiu TH, et al. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8: 399-413.
91. Luna-Zurita L, Prados B, Grego-Bessa J, et al. 2010. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest 120: 3493-3507.
92. Lyons KM, Pelton RW, Hogan BL. 1990. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109: 833-844.
93. Ma L, Lu MF, Schwartz RJ, Martin JF. 2005. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611.
94. MacGrogan D, Nus M, de la Pompa JL. 2010. Notch signaling in cardiac development and disease. Curr Top Dev Biol 92: 333-365.
95. Manasek FJ. 1970. Sulfated extracellular matrix production in the embryonic heart and adjacent tissues. J Exp Zool 174: 415-439.
96. Manasek FJ, Reid M, Vinson W, et al. 1973. Glycosaminoglycan synthesis by the early embryonic chick heart. Dev Biol 35: 332-348.
97. Maron BJ, Hutchins GM. 1974. The development of the semilunar valves in the human heart. Am J Pathol 74: 331-344.
98. McBride KL, Riley MF, Zender GA, et al. 2008. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 17: 2886-2893.
99. McKellar SH, Tester DJ, Yagubyan M, et al. 2007. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 134: 290-296.
100. Mercado-Pimentel ME, Hubbard AD, Runyan RB. 2007. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 304: 420-432.
101. Meyer D, Birchmeier C. 1995. Multiple essential functions of neuregulin in development. Nature 378: 386-390.
102. Meyer D, Yamaai T, Garratt A, et al. 1997. Isoform-specific expression and function of neuregulin. Development 124: 3575-3586.
103. Misfeldt AM, Boyle SC, Tompkins KL, et al. 2009. Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors. Dev Biol 333: 78-89.
104. Mjaatvedt CH, Lepera RC, Markwald RR. 1987. Myocardial specificity for initiating endothelial-mesenchymal cell transition in embryonic chick heart correlates with a particulate distribution of fibronectin. Dev Biol 119: 59-67.
105. Mjaatvedt CH, Yamamura H, Capehart AA, et al. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202: 56-66.
106. Mohamed SA, Aherrahrou Z, Liptau H, et al. 2006. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun 345: 1460-1465.
107. Montero JA, Giron B, Arrechedera H, et al. 2002. Expression of Sox8, Sox9 and Sox10 in the developing valves and autonomic nerves of the embryonic heart. Mech Dev 118: 199-202.
108. Moretti A, Caron L, Nakano A, et al. 2006. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165.
109. Nakajima Y, Mironov V, Yamagishi T, et al. 1997. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn 209: 296-309.
110. Niessen K, Fu Y, Chang L, et al. 2008. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 182: 315-325.
111. Norris RA, Moreno-Rodriguez RA, Sugi Y, et al. 2008. Periostin regulates atrioventricular valve maturation. Dev Biol 316: 200-213.
112. Okubo A, Miyoshi O, Baba K, et al. 2004. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 41: e97.
113. Ozdamar B, Bose R, Barrios-Rodiles M, et al. 2005. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609.
114. Paruchuri S, Yang JH, Aikawa E, et al. 2006. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 99: 861-869.
115. Pentassuglia L, Sawyer DB. 2009. The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 315: 627-637.
116. Person AD, Garriock RJ, Krieg PA, et al. 2005a. Frzb modulates Wnt-9a-mediated beta-catenin signaling during avian atrioventricular cardiac cushion development. Dev Biol 278: 35-48.
117. Person AD, Klewer SE, Runyan RB. 2005b. Cell biology of cardiac cushion development. Int Rev Cytol 243: 287-335.
118. Pizzuti A, Sarkozy A, Newton AL, et al. 2003. Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 22: 372-377.
119. Poelmann RE, Mikawa T, Gittenberger-de Groot AC. 1998. Neural crest cells in outflow tract septation of the embryonic chicken heart: differentiation and apoptosis. Dev Dyn 212: 373-384.
120. Porras D, Brown CB. 2008. Temporal-spatial ablation of neural crest in the mouse results in cardiovascular defects. Dev Dyn 237: 153-162.
121. Posch MG, Gramlich M, Sunde M, et al. 2010. A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet 47: 230-235.
122. Potts JD, Dagle JM, Walder JA, et al. 1991. Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc Natl Acad Sci U S A 88: 1516-1520.
123. Potts JD, Runyan RB. 1989. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Dev Biol 134: 392-401.
124. Puri MC, Partanen J, Rossant J, Bernstein A. 1999. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126: 4569-4580.
125. Puri MC, Rossant J, Alitalo K, Bernstein, et al. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14: 5884-5891.
126. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. 2004. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 13: 841-847.
127. Rabkin E, Aikawa M, Stone JR, et al. 2001. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104: 2525-2532.
128. Ranger AM, Grusby MJ, Hodge MR, et al. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186-190.
129. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, et al. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389: 725-730.
130. Rivera-Feliciano J, Lee KH, Kong SW, et al. 2006. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 133: 3607-3618.
131. Roberts AE, Araki T, Swanson KD, et al. 2007. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39: 70-74.
132. Roberts KE, McElroy JJ, Wong WP, et al. 2004. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 24: 371-374.
133. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659-2670.
134. Satokata I, Ma L, Ohshima H, et al. 2000. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24: 391-395.
135. Satokata I, Maas R. 1994. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 6: 348-356.
136. Schroeder JA, Jackson LF, Lee DC, Camenisch TD. 2003. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 81: 392-403.
137. Schubert FR, Mootoosamy RC, Walters EH, et al. 2002. Wnt6 marks sites of epithelial transformations in the chick embryo. Mech Dev 114: 143-148.
138. Sedmera D, Pexieder T, Vuillemin M, et al. 2000. Developmental patterning of the myocardium. Anat Rec 258: 319-337.
139. Shelton EL, Yutzey KE. 2008. Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev Biol 317: 282-295.
140. Shen R, Ouyang YB, Qu CK, et al. 2002. Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction. Mol Cell Biol 22: 3230-3236.
141. Shi Y, Massagué J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
142. Sibilia M, Wagner B, Hoebertz A, et al. 2003. Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130: 4515-4525.
143. Smith KA, Joziasse IC, Chocron S, et al. 2009. Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 119: 3062-3069.
144. Smith TK, Bader DM. 2007. Signals from both sides: control of cardiac development by the endocardium and epicardium. Semin Cell Dev Biol 18: 84-89.
145. Song L, Fäassler R, Mishina Y, et al. 2007. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Dev Biol 301: 276-286.
146. Sridurongrit S, Larsson J, Schwartz R, et al. 2008. Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev Biol 322: 208-218.
147. Stankunas K, Hang CT, Tsun ZY, et al. 2008. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 14: 298-311.
148. Stennard FA, Costa MW, Elliott DA, et al. 2003. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 262: 206-224.
149. Stennard FA, Costa MW, Lai D, et al. 2005. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132: 2451-2462.
150. Stephen LJ, Fawkes AL, Verhoeve A, et al. 2007. A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 302: 66-79.
151. Sugi Y, Markwald RR. 1996. Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol 175: 66-83.
152. Sugi Y, Markwald RR. 2003. Endodermal growth factors promote endocardial precursor cell formation from precardiac mesoderm. Dev Biol 263: 35-49.
153. Sugi Y, Yamamura H, Okagawa H, Markwald RR. 2004. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev Biol 269: 505-518.
154. Svensson EC, Huggins GS, Lin H, et al. 2000. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet 25: 353-356.
155. Tadano M, Edamatsu H, Minamisawa S, et al. 2005. Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. Mol Cell Biol 25: 2191-2199.
156. Tartaglia M, Kalidas K, Shaw A, et al. 2002. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70: 1555-1563.
157. Tartaglia M, Mehler EL, Goldberg R, et al. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465-468.
158. Tartaglia M, Pennacchio LA, Zhao C, et al. 2007. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39: 75-79.
159. Tevosian SG, Deconinck AE, Tanaka M, et al. 2000. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101: 729-739.
160. Timmerman LA, Grego-Bessa J, Raya A, et al. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18: 99-115.
161. Townsend TA, Robinson, Jamille Y, et al. BMP-2 and TGFβ2 shared pathways regulate endocardial cell transformation. Cells, Tissues, Organs (in press).
162. Townsend TA, Wrana JL, Davis GE, Barnett JV. 2008. Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on PAR6C regulation of Rhoa. J Biol Chem 283: 13834-13841.
163. Verzi MP, McCulley DJ, De Val S, et al. 2005. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. Dev Biol 287: 134-145.
164. Vikkula M, Boon LM, Carraway KL3rd, et al. 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87: 1181-1190.
165. Wang J, Sridurongrit S, Dudas M, et al. 2005. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol 286: 299-310.
166. Wang XF, Lin HY, Ng-Eaton E, et al. 1991. Expression cloning and characterization of the TGF-beta type III receptor. Cell 67: 797-805.
167. Wei Y, Mikawa T. 2000. Fate diversity of primitive streak cells during heart field formation in ovo. Dev Dyn 219: 505-513.
168. Wessels A, Markman MW, Vermeulen JL, et al. 1996. The development of the atrioventricular junction in the human heart. Circ Res 78: 110-117.
169. Wiley LM, Wu JX, Harari I, Adamson ED. 1992. Epidermal growth factor receptor mRNA and protein increase after the four-cell preimplantation stage in murine development. Dev Biol 149: 247-260.
170. Yamada M, Szendro PI, Prokscha A, et al. 1999. Evidence for a role of Smad6 in chick cardiac development. Dev Biol 215: 48-61.
171. Yamagishi T, Nakajima Y, Nishimatsu S, et al. 2004. Expression of tbx20 RNA during chick heart development. Dev Dyn 230: 576-580.
172. Yutzey KE, Colbert M, Robbins J. 2005. Ras-related signaling pathways in valve development: ebb and flow. Physiology (Bethesda) 20: 390-397.
173. Zanin MK, Bundy J, Ernst H, et al. 1999. Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart. Anat Rec 256: 366-380.